NovaBay Pharmaceuticals, Inc.
NBYNovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
Drugs in Pipeline
6
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How NBY's past catalysts played out
Experimental: CD07223 1.5 % Topical Gel BID
Impetigo
NVC-422
Impetigo
Auriclosene Solution 0.3%
Bacterial Conjunctivitis
NVC-422 Solution, 0.3%
Adenoviral Conjunctivitis
sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate
Asymptomatic Bacteriuria
NVC-422, 0.2%
Urinary Catheter Blockage and Encrustation
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Experimental: CD07223 1.5 % Topical Gel BID | Phase 3 | Impetigo | - | - |
NVC-422 | Phase 2 | Impetigo | - | - |
Auriclosene Solution 0.3% | Phase 2 | Bacterial Conjunctivitis | - | - |
NVC-422 Solution, 0.3% | Phase 2 | Adenoviral Conjunctivitis | - | - |
sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate | Phase 2 | Asymptomatic Bacteriuria | - | - |
NVC-422, 0.2% | Phase 2 | Urinary Catheter Blockage and Encrustation | - | - |
Impetigo
2 drugs in this indication
Adenoviral Conjunctivitis
1 drug in this indication
Asymptomatic Bacteriuria
1 drug in this indication
Bacterial Conjunctivitis
1 drug in this indication
Urinary Catheter Blockage and Encrustation
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in NovaBay Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in NovaBay Pharmaceuticals, Inc.'s (NBY) pipeline across Phase 3, Phase 2. Its lead program is Experimental: CD07223 1.5 % Topical Gel BID (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NovaBay Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NovaBay Pharmaceuticals, Inc. (NBY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NBY biotech catalysts?→
Add NBY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NovaBay Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.